Feds Taking Another Shot at 340B Changes
Only a week after a federal court rejected for a second time its attempt to introduce a new approach to administering the 340B Drug Pricing Program, the Health Resources and Services Administration is going back to the drawing board and trying again to launch the model. In its first step, HRSA has issued a Request for Information (RFI) to gather input from interested parties on whether the agency should implement a rebate model under the 340B program and how best to implement such a model. The RFI notes that in 2024, HRSA began receiving inquiries from drug companies seeking to [...]
